Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study1 1The other PROACTIVE Study Group investigators included the following: Vijayan Balan, M.D., Mayo Clinic Scottsdale, Scottsdale, Arizona; Norbert Bräu, M.D., Bronx VA Medical Center, Bronx, New York; Robert Brown, M.D., M.P.H., NY Presbyterian Medical Center, New York, New York; William Carey, M.D., Cleveland Clinic Foundation, Cleveland, Ohio; Andrea Duchini, M.D., Baylor College of Medicine, Houston, Texas; Greg Everson, M.D., University of Colorado Health Sciences Center, Denver, Colorado; Michael Fried, M.D., University of North Carolina, Chapel Hill, North Carolina; Robert Gish, M.D., California Pacific Medical Center, San Francisco, California; Ira Jacobson, M.D., Weill Medical College of Cornell University, New York, New York; John W. King, LSU Health Sciences Center, Shreveport, LA; Raymond Koff, M.D., University of Massachusetts Memorial Health Care, Worcester, Massachusetts; William Lee, M.D., University of Texas Southwestern Medical Center, Dallas, Texas; Mark A. Levstik, M.D., The University of Tennessee, Memphis, Tennessee; John G. McHutchison, M.D., Scripps Clinic, La Jolla, California; Marion Peters, M.D., University of California San Francisco, San Francisco, California; Kenneth Sherman, M.D., Ph.D., University of Cincinnati College of Medicine, Cincinnati, Ohio; Coleman Smith, M.D., Minnesota Clinical Research Center, St. Paul, MN; Ronald Wasserman, M.D., Hepatitis Resource Center, Walnut Creek, California

Autor: Mitchell L. Shiffman, Mark S. Sulkowski, Zobair M. Younossi, Paul J. Pockros, Eugene R. Schiff, Peter J. Bowers, Betty L. Goon, Douglas T. Dieterich, Nezam H. Afdhal, K. Linda Tang, Teresa L. Wright

Publikováno v: Gastroenterology. 126:1302-1311

Background & Aims: Combination therapy with interferon α (IFN-α) and ribavirin (RBV) or pegylated IFN-α (PEG-IFN-α)/RBV for chronic hepatitis C virus (HCV) infection often causes anemia, prompting RBV dose reduction/discontinuation. This study as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71e7b0ebf629de21132180cdc98cfc3b
https://doi.org/10.1053/j.gastro.2004.01.027

Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial

Autor: Demeyer, H, Louvaris, Z, Frei, A, Rabinovich, RA, De Jong, C, Gimeno-Santos, E, Loeckx, M, Buttery, SC, Rubio, N, Van der Molen, T, Hopkinson, NS, Vogiatzis, I, Puhan, MA, Garcia-Aymerich, J, Polkey, MI, Troosters, T, On behalf of the Mr Papp PROactive study group and the PROactive consortium

Publikováno v: THORAX
Thorax
Dipòsit Digital de la UB
Universidad de Barcelona
Thorax, 72(5), 415-423. BMJ PUBLISHING GROUP
Recercat. Dipósit de la Recerca de Catalunya
instname

RATIONALE: Reduced physical activity (PA) in patients with COPD is associated with a poor prognosis. Increasing PA is a key therapeutic target, but thus far few strategies have been found effective in this patient group. OBJECTIVES: To investigate th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a4b90375895fc68a08bb2ad4d5b6e0
http://hdl.handle.net/2445/107161

JACQLQ subjective symptom questionnaire score and clinical test results for patients with allergic conjunctival disease.

Autor: Yamana, Yasuo¹ (AUTHOR) yamanaganka@yamana.or.jp, Yamana, Satoshi² (AUTHOR), Uchio, Eiichi³ (AUTHOR)

Publikováno v: Scientific Reports. 7/14/2024, Vol. 14 Issue 1, p1-9. 9p.

Physical activity is increased by a 12-week semiautomated telecoaching programme in patients with COPD: a multicentre randomised controlled trial.

Autor: Demeyer H; KU Leuven, Department of Rehabilitation Sciences, Leuven, Belgium.; University hospitals Leuven, Department of Respiratory Diseases, Leuven, Belgium.; IS Global, Center for research in Environmental epidemiology (CREAL), Barcelona, Spain., Louvaris Z; National and Kapodistrian University of Athens, Faculty of Physical Education and Sports Sciences Athens, GR., Frei A; Department of Epidemiology, University of Zurich, Biostatistics and Prevention Institute, Zurich, Switzerland., Rabinovich RA; ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK., de Jong C; GRIAC-Primary Care, department of general practice and elderly care, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands., Gimeno-Santos E; IS Global, Center for research in Environmental epidemiology (CREAL), Barcelona, Spain.; CIBER Epidemiologica y Salud Publica (CIBERESP), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Loeckx M; KU Leuven, Department of Rehabilitation Sciences, Leuven, Belgium.; University hospitals Leuven, Department of Respiratory Diseases, Leuven, Belgium., Buttery SC; Royal Brompton and Harefiled NHS Foundation Trust and Imperial College, NIHR Respiratory Biomedical Research Unit, London, UK., Rubio N; ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK., Van der Molen T; GRIAC-Primary Care, department of general practice and elderly care, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands., Hopkinson NS; Royal Brompton and Harefiled NHS Foundation Trust and Imperial College, NIHR Respiratory Biomedical Research Unit, London, UK., Vogiatzis I; National and Kapodistrian University of Athens, Faculty of Physical Education and Sports Sciences Athens, GR.; National and Kapodistrian University of Athens, Faculty of Physical Education and Sports Sciences Athens, GR., Puhan MA; Department of Epidemiology, University of Zurich, Biostatistics and Prevention Institute, Zurich, Switzerland., Garcia-Aymerich J; IS Global, Center for research in Environmental epidemiology (CREAL), Barcelona, Spain.; CIBER Epidemiologica y Salud Publica (CIBERESP), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Polkey MI; Royal Brompton and Harefiled NHS Foundation Trust and Imperial College, NIHR Respiratory Biomedical Research Unit, London, UK., Troosters T; KU Leuven, Department of Rehabilitation Sciences, Leuven, Belgium.; University hospitals Leuven, Department of Respiratory Diseases, Leuven, Belgium.

Publikováno v: Thorax [Thorax] 2017 May; Vol. 72 (5), pp. 415-423. Date of Electronic Publication: 2017 Jan 30.

Physical activity, sedentary time and gain in overall and central body fat: 7-year follow-up of the ProActive trial cohort.

Autor: Golubic R; Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK., Wijndaele K; Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK., Sharp SJ; Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK., Simmons RK; Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK., Griffin SJ; Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK., Wareham NJ; Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK., Ekelund U; 1] Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK [2] Department of Sport Medicine, Norwegian School of Sport Sciences, Oslo, Norway., Brage S; Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.

Publikováno v: International journal of obesity (2005) [Int J Obes (Lond)] 2015 Jan; Vol. 39 (1), pp. 142-8. Date of Electronic Publication: 2014 Apr 15.